The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology ...
Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...
The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...
Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. | Microsoft ...
News-Medical.Net on MSN
Cancer mortality drops 34% as treatments and early detection improve
The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...
Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal ...
Cancer care remains a significant global healthcare challenge, with critical concerns surrounding symptom management and ...
Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction, improving the ability to ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
News Medical on MSN
Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback